UPMC Cancer Center - Passavant — Pittsburgh, Pennsylvania

UPMC Cancer Center - Passavant is a clinical research site located in Pittsburgh, Pennsylvania, United States 15237.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

UPMC Cancer Center - Passavant has participated in 3 clinical trials.

Therapeutic areas: Small Cell Lung Cancer, Adenoid Cystic Carcinoma, Adenoma, Pleomorphic.

Sponsors: Ahmad Tarhini, University of Pittsburgh.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Cancer Center - Passavant?

UPMC Cancer Center - Passavant has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Cancer Center - Passavant conducted?

UPMC Cancer Center - Passavant has 3 clinical trials on record. Their work covers Small Cell Lung Cancer, Adenoid Cystic Carcinoma, Adenoma, Pleomorphic.

Is UPMC Cancer Center - Passavant accredited by Crixeo Health?

UPMC Cancer Center - Passavant has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Cancer Center - Passavant?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.